Company intelligence / Profile preview

INSOUL

Shenzhen, Guangdong, China

Ownership: Private
Development stage: Other

Overview

INSOUL (Shenzhen Insoul Medical Technology) is a Chinese medical technology company specializing in advanced diabetes management solutions. The company develops and manufactures high-end medical devices, including patch insulin pump systems and continuous glucose monitoring (CGM) devices. Its flagship products are designed to provide precise insulin delivery and real-time glucose tracking to improve the quality of life for patients with diabetes. INSOUL focuses on integrating micro-fluidic technology and intelligent algorithms into its wearable medical devices to create a closed-loop artificial pancreas system.

Therapeutic areas: Endocrinology
Modalities: Device
Industry: Therapeutic Medical Devices

Beyond the preview

Go deeper on INSOUL.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on INSOUL.

Explore the full profile